The proposed bill would significantly update current statutes related to stem cell and regenerative therapies in Arizona. It would introduce new definitions for provider and stem cell or regenerative therapy, broadening the scope of who can administer these therapies. The legislation, designated as the Arizona Stem Cell and Regenerative Therapy Act, would remove previous prohibitions on using cells or tissues derived from aborted fetuses or embryos, along with associated felony penalties. Additionally, it would replace the term physician with provider and birth tissue therapy with regenerative therapy, while eliminating the authority of the Arizona Medical Board and the Board of Osteopathic Examiners to adopt related rules. The bill would also implement various requirements for providers, including training, sourcing, and informed consent for administering therapies, and mandates for facilities to comply with good manufacturing practices. It would require detailed documentation of treatment records and clinical outcomes, deem violations as unprofessional conduct, and establish penalties for non-compliance, allowing harmed individuals to seek civil damages. Overall, these changes aim to enhance the regulatory framework surrounding stem cell and regenerative therapies, ensuring patient safety and legal protections for both providers and patients.

Statutes affected:
Introduced Version: